Kaisa Huhtinen

ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors (2020)

Journal of Pathology

Katja Kaipio, Ping Chen, Pia Roering, Kaisa Huhtinen, Piia Mikkonen, Päivi Östling, Laura Lehtinen, Naziha Mansuri, Taina Korpela, Swapnil Potdar, Johanna Hynninen, Annika Auranen, Seija Grénman, Krister Wennerberg, Sampsa Hautaniemi, Olli Carpén

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions (2020)

Scientific Data

Gabriel M, Fey V, Heinosalo T, Adhikari P, Rytkönen K, Komulainen T, Huhtinen K, Laajala TD, Siitari H, Virkki A, Suvitie P, Kujari H, Aittokallio T, Perheentupa A, Poutanen M

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

American Association for Cancer Research Special Conference on Advances in Ovarian Cancer Research Sep 13-16, 2019 Atlanta, GA, USA Abstracts (2020)

Clinical Cancer Research

Oikkonen J, Sanz NC, Hakkinen A, Li YL, Schulman I, Kivikoski M, Huhtinen K, Hietanen S, Grenman SE, Hynninen J, Lehtonen R, Hautaniemi S

(O2 Muu)

RNA-seq analysis of high-grade serous ovarian cancer patients before and after chemotherapy reveals chemoresistance-associated genes and pathways (2020)

Clinical Cancer Research

Jamalzadeh S, Zhang KY, Hakkinen A, Huhtinen K, Hynninen J, Andersson N, Mansuri N, Carpen O, Erdogan E, Dai J, Vaharautio A, Hietanen S, Oikkonen J, Lehtonen R, Hautaniemi S

(O2 Muu)

A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer (2020)

Gynecologic Oncology

Liina Salminen, Nimrah Nadeem, Shruti Jain, Seija Grènman, Olli Carpén, Sakari Hietanen, Sinikka Oksa, Urpo Lamminmäki, Kim Pettersson, Kamlesh Gidwani, Kaisa Huhtinen, Johanna Hynninen

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy (2020)

Cancer Discovery

Sonia Iyer, Shuang Zhang, Simge Yucel, Heiko Horn, Sean G Smith, Ferenc Reinhardt, Esmee Hoefsmit, Bimarzhan Assatova, Julia Casado, Marie-Charlotte Meinsohn, M Inmaculada Barrasa, George W Bell, Fernando Perez-Villatoro, Kaisa Huhtinen, Johanna Hynninen, Jaana Oikkonen, Pamoda M Galhenage, Shailja Pathania, Paula T Hammond, Benjamin G Neel, Anniina Färkkilä, David Pépin, Robert A. Weinberg

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Analysis of single-cell RNA-seq data from ovarian cancer samples before and after chemotherapy links stress-related transcriptional profile with chemotherapy resistance (2020)

bioRxiv

Zhang K, Erkan EP, Dai J, Andersson N, Kaipio K, Lamminen T, Mansuri N, Huhtinen K, Carpen O, Hynninen J, others

(O2 Muu)

Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 (2020)

Communications Biology

Sherif Bayoumy, Heidi Hyytiä, Janne Leivo, Sheikh M. Talha, Kaisa Huhtinen, Matti Poutanen, Johanna Hynninen, Antti Perheentupa, Urpo Lamminmäki, Kamlesh Gidwani & Kim Pettersson

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer (2020)

Clinical Cancer Research

Erkan EP, Dai J, Zhang KY, Kaipio K, Lamminen T, Mansuri N, Suominen L, Alkodsi A, Huhtinen K, Hietanen S, Hynninen J, Grenman S, Carpen O, Hautaniemi S, Vaharautio A

(O2 Muu)

Exploratory Analysis of CA125-MGL and –STn Glycoforms in the Differential Diagnostics of Pelvic Masses (2020)

The Journal of Applied Laboratory Medicine

Liina Salminen, Nimrah Nadeem, Anne Lone Rolfsen, Anne Dørum, Teemu D Laajala, Seija Grènman, Sakari Hietanen, Taija Heinosalo, Antti Perheentupa, Matti Poutanen, Nils Bolstad, Olli Carpén, Urpo Lamminmäki, Kim Pettersson, Kamlesh Gidwani, Johanna Hynninen, Kaisa Huhtinen

(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)

Ota yhteyttä

Linkit

Asiantuntijuusalueet

Julkaisut

Järjestä:

ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors (2020)

A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions (2020)

American Association for Cancer Research Special Conference on Advances in Ovarian Cancer Research Sep 13-16, 2019 Atlanta, GA, USA Abstracts (2020)

RNA-seq analysis of high-grade serous ovarian cancer patients before and after chemotherapy reveals chemoresistance-associated genes and pathways (2020)

A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer (2020)

Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy (2020)

Analysis of single-cell RNA-seq data from ovarian cancer samples before and after chemotherapy links stress-related transcriptional profile with chemotherapy resistance (2020)

Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 (2020)

Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer (2020)

Exploratory Analysis of CA125-MGL and –STn Glycoforms in the Differential Diagnostics of Pelvic Masses (2020)